Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial

Triple artemisinin-based combination therapies (TACTs) are efficacious, well tolerated, and safe treatments of uncomplicated P falciparum malaria, including in areas with artemisinin and Artemisinin-based combination therapies (ACT) partner-drug resistance. The Lancet

Other news